Annual Report Searches
Alphabetical Search

Advertisers


JOHNSON & JOHNSON (JNJ:NYSE)

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.


Yearly Figures
(in millions, except per share amounts)
FYE: 12/31 2025 2024 2023 2022
Net Revenues $94,193 $88,821 $85,159 $79,990
Net Income $26,804 $14,066 $35,153 $17,941
Earnings Per Share 11.03 5.79 13.72 6.73
Quarterly Figures
(in thousands, except per share amounts)
              Fourth Quarter
FYE: 12/31 12/31/25 12/31/24
Net Revenues $24,564 $22,520
Net Income $5,116 $3,431
Earnings Per Share 2.10 1.41
Contact Information
Contact Name: Raavi Deol
Contact Title: Corporate Governance Specialist
Phone: 732-524-0400